FEATURED COMPANIES
- Bayer Healthcare.
- Dexcom Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
The mHealth market accounted for $46,048 million in 2019, and is expected to reach $230,419 million by 2027, registering a CAGR of 22.3% from 2020 to 2027.
Electronic health (eHealth) is defined as collection and storage of patient data on a computer. Furthermore, Mobile health (mHealth) is a branch of eHealth, which involves the use of mobile devices such as mobile phones, tablets, wearable devices, personal digitals assistants (PDAs), and others to collect and store medical data. In addition, mHealth majorly involves the use of mobile and wireless technologies, which are deployed in monitoring and treatment of several acute and chronic disorders. Some of the other services, offered by the use of mHealth include, prevention of diseases, diagnosis of diseases, and wellness & healthcare system strengthening solutions. In addition, some of the clinical fields that use mHealth devices and services include cardiovascular diseases, diabetes, respiratory, neurology, and others. Furthermore, some of the mHealth devices present in the market include blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, and others.
The major factors that contribute toward the growth of the mHealth market include rise in prevalence of lifestyle disorders. Furthermore, factors such as technological innovations, and favorable government initiatives also boost the growth of the mHealth market. In addition, integration of wireless technologies with portable healthcare devices is another major factor that fuels the growth of the market. Moreover, affordability of smartphones and rise in adoption of mHealth among medical professionals also boost the growth of the market.
However, weak reimbursement coverage associated with mHealth and lack of technological awareness among the aging population hinder the growth of the market. Conversely, lucrative growth potential offered by untapped market of developing economies offers a lucrative opportunity for the mHealth market.
The global mHealth market is segmented on the basis of device, service, stakeholder, application, and region to provide a detailed assessment of the market. By device, the market is divided into blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. By service, it is classified into prevention, diagnostic services, monitoring services, treatment, and wellness & healthcare system strengthening solutions. By stakeholder, it is divided into mobile operators, device vendors, healthcare providers, and Application & Content Players. By application, it is classified into cardiovascular diseases, diabetes, respiratory diseases, neurology diseases, and others. By region, the mHealth market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and Middle East (Saudi Arabia, Kuwait, UAE, Qatar, Bahrain, Oman, rest of Middle East), and Latin America & Africa.
Major players operating in the market include Bayer Healthcare., Boston Scientific Corporation, Dexcom, Inc., Johnson & Johnson, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Omron Corporation, Samsung Group, and Sanofi.
KEY BENEFITS FOR STAKEHOLDERS
Key Market Segments
By Type
By Stakeholders
By Application
By Region
List of key players profiled in the report
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Electronic health (eHealth) is defined as collection and storage of patient data on a computer. Furthermore, Mobile health (mHealth) is a branch of eHealth, which involves the use of mobile devices such as mobile phones, tablets, wearable devices, personal digitals assistants (PDAs), and others to collect and store medical data. In addition, mHealth majorly involves the use of mobile and wireless technologies, which are deployed in monitoring and treatment of several acute and chronic disorders. Some of the other services, offered by the use of mHealth include, prevention of diseases, diagnosis of diseases, and wellness & healthcare system strengthening solutions. In addition, some of the clinical fields that use mHealth devices and services include cardiovascular diseases, diabetes, respiratory, neurology, and others. Furthermore, some of the mHealth devices present in the market include blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, and others.
The major factors that contribute toward the growth of the mHealth market include rise in prevalence of lifestyle disorders. Furthermore, factors such as technological innovations, and favorable government initiatives also boost the growth of the mHealth market. In addition, integration of wireless technologies with portable healthcare devices is another major factor that fuels the growth of the market. Moreover, affordability of smartphones and rise in adoption of mHealth among medical professionals also boost the growth of the market.
However, weak reimbursement coverage associated with mHealth and lack of technological awareness among the aging population hinder the growth of the market. Conversely, lucrative growth potential offered by untapped market of developing economies offers a lucrative opportunity for the mHealth market.
The global mHealth market is segmented on the basis of device, service, stakeholder, application, and region to provide a detailed assessment of the market. By device, the market is divided into blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. By service, it is classified into prevention, diagnostic services, monitoring services, treatment, and wellness & healthcare system strengthening solutions. By stakeholder, it is divided into mobile operators, device vendors, healthcare providers, and Application & Content Players. By application, it is classified into cardiovascular diseases, diabetes, respiratory diseases, neurology diseases, and others. By region, the mHealth market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and Middle East (Saudi Arabia, Kuwait, UAE, Qatar, Bahrain, Oman, rest of Middle East), and Latin America & Africa.
Major players operating in the market include Bayer Healthcare., Boston Scientific Corporation, Dexcom, Inc., Johnson & Johnson, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Omron Corporation, Samsung Group, and Sanofi.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global antihypertensive market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
By Type
- mHealth Devices
- Blood Glucose Meters
- BP Monitors
- Pulse Oximetry
- Neurological Monitors
- Cardiac Monitors
- Apnea & Sleep Monitors
- Wearable Fitness Sensor Device & Heart Rate Meters
- Others
- mHealth Services
- Prevention
- Diagnostic Services
- Monitoring Services
- Treatment
- Wellness & Healthcare System Strengthening Solutions
By Stakeholders
- Mobile Operators
- Device Vendors
- Healthcare Providers
- Application & Content Players
By Application
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Neurological Diseases
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- Middle East
- Saudi Arabia
- Kuwait
- UAE
- Qatar
- Bahrain
- Oman
- Rest of Middle East
- Latin America
- Latin America
- Africa
List of key players profiled in the report
- Bayer Healthcare
- Boston Scientific Corporation
- Dexcom, Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- Omron Corporation
- Samsung Group
- Sanofi
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- Allscripts Healthcare Solutions, Inc.
- SoftServe, Inc.,
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Bayer Healthcare.
- Dexcom Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Mhealth Market, by Type
Chapter 5: Mhealth Market, by Stakeholders
Chapter 6: Mhealth Market, by Application
Chapter 7: Mhealth Market, by Region
Chapter 8: Company Profiles
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Bayer Healthcare.
- Dexcom Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
According to the report titled, "mHealth Market by Type, Stakeholders, and Application: Opportunity Analysis and Industry Forecast, 2019-2027,"the global mHealth market was valued at $46 billion in 2019, and is expected to reach $230 billion by 2027, registering a CAGR of 22.3% from 2020 to 2027.
Mobile health is a branch of electronic health, which is defined as medical and public health practice supported by mobile devices. The mobile devices used in mHealth include mobile phones, patient monitoring devices, personal digital assistants, and other devices. These devices are utilized to collect and store patient information to obtain accurate results, which are used to treat and diagnose various medical conditions such as diabetes, blood pressure, and others. In addition, other mHealth services include prevention of diseases, monitoring of diseases, and others. Furthermore, these services are used in various clinical fields such as diabetes, respiratory diseases, cardiovascular diseases, and others. Moreover, some of the mHealth devices offered by various key players in the market include blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, and others.
The major factor that contributes toward the growth of the mHealth market include rise in prevalence of lifestyle diseases. Furthermore, factors such as technological innovations, integration of wireless technologies with portable healthcare devices, affordability of smartphones, rise in adoption of mHealth among medical professionals, and favorable government initiatives also boost of mHealth market growth. However, weak reimbur sement coverage associated with mHealth and lack on technological awareness among the aging population hinder the growth of the market. Conversely, lucrative growth potential offered by untapped market of developing economies offers a lucrative opportunity for the mobile health market.
The global mHealth market is segmented on the basis of device, service, stakeholder, application, and region to provide a detailed assessment of the market. By device, the market is divided into blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. By service, it is classified into prevention, diagnostic services, monitoring services, treatment, and wellness & healthcare system strengthening solutions. By stakeholder, it is divided into mobile operators, device vendors, healthcare providers, and Application & Content Players. By application, it is categorized into cardiovascular diseases, diabetes, respiratory diseases, neurology diseases, and others. By region, the mHealth market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and Middle East (Saudi Arabia, Kuwait, UAE, Qatar, Bahrain, Oman, and rest of Middle East), and Latin America & Africa.
On the basis of device, BP monitors held the dominant share in 2019, owing to the factors such as surge in incidence of hypertension, which leads to high blood pressure, and rise in adoption of sedentary lifestyle. However, blood glucose meters is estimated to be the fastest growing segment in the global mHealth devices market due to rise in prevalence of diabetes and surge in adoption of continuous blood glucose monitoring (CGM) devices.
By service, the monitoring services occupied the largest share of mHealth services market in 2019 and is also expected to exhibit fastest growth rate during the forecast period. The growth of the segment is due to factors such as rise in prevalence of diseases, which include blood pressure, diabetes, and cardiovascular diseases which require monitoring of the condition of the patient for prevention and better treatment.
In 2019, North America accounted for the major share of mHealth market size and is expected to continue this trend owing to rise in prevalence of diabetes, blood pressure, cardiovascular diseases, and others. Moreover, other factors such as easy availability of mHealth devices and services, and surge in adoption of these devices boost the market growth in this region. Asia-Pacific is expected to exhibit fastest growth rate owing to surge in awareness related to use of mHealth devices. The other factors that boost the growth of the market include huge patient base of diabetes and rise in healthcare expenditure in the region. The developing economies offer lucrative opportunities for mHealth providers to expand their business.
Key Findings Of The Study
By type, the mHealth services segment occupied approximately two-thirds share of the global mHealth market in 2019.
By application, the cardiovascular diseases segment occupied approximately half of the global mHealth market share in 2019.
By application, the neurological diseases segment is anticipated to grow with the highest CAGR throughout the forecast period.
By stakeholders, the healthcare providers segment is anticipated to grow with the highest CAGR throughout the mHealth market forecast period.
By region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by Middle East.
Mobile health is a branch of electronic health, which is defined as medical and public health practice supported by mobile devices. The mobile devices used in mHealth include mobile phones, patient monitoring devices, personal digital assistants, and other devices. These devices are utilized to collect and store patient information to obtain accurate results, which are used to treat and diagnose various medical conditions such as diabetes, blood pressure, and others. In addition, other mHealth services include prevention of diseases, monitoring of diseases, and others. Furthermore, these services are used in various clinical fields such as diabetes, respiratory diseases, cardiovascular diseases, and others. Moreover, some of the mHealth devices offered by various key players in the market include blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, and others.
The major factor that contributes toward the growth of the mHealth market include rise in prevalence of lifestyle diseases. Furthermore, factors such as technological innovations, integration of wireless technologies with portable healthcare devices, affordability of smartphones, rise in adoption of mHealth among medical professionals, and favorable government initiatives also boost of mHealth market growth. However, weak reimbur sement coverage associated with mHealth and lack on technological awareness among the aging population hinder the growth of the market. Conversely, lucrative growth potential offered by untapped market of developing economies offers a lucrative opportunity for the mobile health market.
The global mHealth market is segmented on the basis of device, service, stakeholder, application, and region to provide a detailed assessment of the market. By device, the market is divided into blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. By service, it is classified into prevention, diagnostic services, monitoring services, treatment, and wellness & healthcare system strengthening solutions. By stakeholder, it is divided into mobile operators, device vendors, healthcare providers, and Application & Content Players. By application, it is categorized into cardiovascular diseases, diabetes, respiratory diseases, neurology diseases, and others. By region, the mHealth market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and Middle East (Saudi Arabia, Kuwait, UAE, Qatar, Bahrain, Oman, and rest of Middle East), and Latin America & Africa.
On the basis of device, BP monitors held the dominant share in 2019, owing to the factors such as surge in incidence of hypertension, which leads to high blood pressure, and rise in adoption of sedentary lifestyle. However, blood glucose meters is estimated to be the fastest growing segment in the global mHealth devices market due to rise in prevalence of diabetes and surge in adoption of continuous blood glucose monitoring (CGM) devices.
By service, the monitoring services occupied the largest share of mHealth services market in 2019 and is also expected to exhibit fastest growth rate during the forecast period. The growth of the segment is due to factors such as rise in prevalence of diseases, which include blood pressure, diabetes, and cardiovascular diseases which require monitoring of the condition of the patient for prevention and better treatment.
In 2019, North America accounted for the major share of mHealth market size and is expected to continue this trend owing to rise in prevalence of diabetes, blood pressure, cardiovascular diseases, and others. Moreover, other factors such as easy availability of mHealth devices and services, and surge in adoption of these devices boost the market growth in this region. Asia-Pacific is expected to exhibit fastest growth rate owing to surge in awareness related to use of mHealth devices. The other factors that boost the growth of the market include huge patient base of diabetes and rise in healthcare expenditure in the region. The developing economies offer lucrative opportunities for mHealth providers to expand their business.
Key Findings Of The Study
By type, the mHealth services segment occupied approximately two-thirds share of the global mHealth market in 2019.
By application, the cardiovascular diseases segment occupied approximately half of the global mHealth market share in 2019.
By application, the neurological diseases segment is anticipated to grow with the highest CAGR throughout the forecast period.
By stakeholders, the healthcare providers segment is anticipated to grow with the highest CAGR throughout the mHealth market forecast period.
By region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by Middle East.
Note: Product cover images may vary from those shown
- Bayer Healthcare.
- Boston Scientific Corporation
- Dexcom Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- Omron Corporation
- Samsung Group
- Sanofi
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
